DiaMedica Therapeutics Inc. (DMAC)
Nasdaq: DMAC · Pharmaceutical Preparations · Minneapolis, MN · filing with the SEC since 2007
Who owns DiaMedica Therapeutics Inc.
As filed with the SECHolders of 5% or more
4
Trill Ab holds 16.9% of Common Shares, no par value, as its SCHEDULE 13G/A filed Feb 6, 2026 says.
Directors and officers
9
report now, of 20 people on the record since 2018. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
Trill Ab
SCHEDULE 13G/A · filed Feb 6, 2026 · Common Shares, no par value · 15% in Sep 4, 2025
TomEnterprise AB
SCHEDULE 13G/A · filed Jul 30, 2025 · Common Shares, no par value
Richard Jacinto II
SCHEDULE 13G/A · filed Nov 7, 2025 · Voting Common Shares, no par value
Cooperman Leon G.
SCHEDULE 13G/A · filed Feb 17, 2026 · Voting Common Shares, no par value · 6.3% in Oct 15, 2025
John Fichthorn
SCHEDULE 13G/A · filed Feb 17, 2026 · Voting common shares, no par value per share · reported falling below 5%
What DMAC reports owning in othersstakes of 5% or more, and other ties
DiaMedica Therapeutics Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2023 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 27 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Trill Ab | 10% owner | 0 | $0 | 0 | 7 | $7.6M |